StockData
Medtronic plc logo

Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic cardiovascular Portfolio — Worldwide Revenue ($M) ($M)

Effective Q1 FY2027, Medtronic reorganized Cardiovascular from 3 divisions (CRHF, SHA, CPV) into 4 divisions (EP Therapies, IC Therapies, CV Surgery, PV Health) without publishing Q2–Q4 FY2026 restated quarters yet; legacy 3 divisions are retained through FY2026Q4 per Step 5, while new divisions (<3 consecutive quarters) are in excluded.

QuarterlyAnnual
Latest, Q1 FY27
3,927
Period ended Jul 31, 2026
Change on a year earlier
+19.5%
3,285 in Q1 FY26
History
26 quarters
Since Q4 FY20
Sources
22
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCardiovascular Portfolio — Worldwide Revenue ($M) ($M)Year on yearSource
Q1 FY27Jul 31, 20263,927+19.5%Medtronic SEC 8K_EARNINGS — FY2027Q1 (filed 2026-09-01) ↗
Q4 FY26Apr 30, 20263,797+13.8%Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗
Q3 FY26Jan 31, 20263,457+13.8%Medtronic SEC 8K_EARNINGS — FY2026Q3 (filed 2026-02-17) ↗
Q2 FY26Oct 31, 20253,436+10.8%Medtronic SEC 8K_EARNINGS — FY2026Q2 (filed 2025-11-18) ↗
Q1 FY26Jul 31, 20253,285+9.2%Medtronic SEC 8K_EARNINGS — FY2027Q1 (filed 2026-09-01) ↗
Q4 FY25Apr 30, 20253,336+6.6%Medtronic SEC 8K_EARNINGS — FY2026Q4 (filed 2026-06-03) ↗
Q3 FY25Jan 31, 20253,037+3.7%Medtronic SEC 8K_EARNINGS — FY2026Q3 (filed 2026-02-17) ↗
Q2 FY25Oct 31, 20243,102+6.1%Medtronic SEC 8K_EARNINGS — FY2026Q2 (filed 2025-11-18) ↗
Q1 FY25Jul 31, 20243,007+5.5%Medtronic SEC 8K_EARNINGS — FY2026Q1 (filed 2025-08-19) ↗
Q4 FY24Apr 30, 20243,130-5.2%Medtronic SEC 8K_EARNINGS — FY2025Q4 (filed 2025-05-21) ↗
Q3 FY24Jan 31, 20242,929+6.1%Medtronic SEC 8K_EARNINGS — FY2025Q3 (filed 2025-02-18) ↗
Q2 FY24Oct 31, 20232,923+5.9%Medtronic SEC 8K_EARNINGS — FY2025Q2 (filed 2024-11-19) ↗
Q1 FY24Jul 31, 20232,850+5.5%Medtronic SEC 8K_EARNINGS — FY2025Q1 (filed 2024-08-20) ↗
Q4 FY23Apr 30, 20233,302+11.5%Medtronic SEC 8K_EARNINGS — FY2024Q4 (filed 2024-05-23) ↗
Q3 FY23Jan 31, 20232,760+0.5%Medtronic SEC 8K_EARNINGS — FY2024Q3 (filed 2024-02-20) ↗
Q2 FY23Oct 31, 20222,759-2.4%Medtronic SEC 8K_EARNINGS — FY2024Q2 (filed 2023-11-21) ↗

Breakdown

What makes up cardiovascular portfolio — worldwide revenue ($m)

Cite this data

StockData. (2026). Medtronic Cardiovascular Portfolio — Worldwide Revenue ($M) ($M), quarterly Q4 FY20–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/cv-port-ww-rev

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.